Takara Bio USA Wins EU Opposition Hearing, Revoking Jumpcode Genomics’ NGS Library Enrichment Patent

SAN JOSE, Calif.–(BUSINESS WIRE)– #NGS–The validity of Takara Bio USA ribosomal RNA depletion patent was confirmed after Jumpcode Genomics patent was revoked during EU opposition hearing.
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks